Dihydrotanshinone-I and Cardiovascular-Diseases

Dihydrotanshinone-I has been researched along with Cardiovascular-Diseases* in 1 studies

Reviews

1 review(s) available for Dihydrotanshinone-I and Cardiovascular-Diseases

ArticleYear
Pharmacological activities of dihydrotanshinone I, a natural product from Salvia miltiorrhiza Bunge.
    Pharmacological research, 2019, Volume: 145

    Salvia miltiorrhiza Bunge (Danshen), a famous traditional Chinese herb, has been used clinically for the treatment of various diseases for centuries. Document data showed that tanshinones, a class of lipophilic abietane diterpenes rich in this herb, possess multiple biological effects in vitro and in vivo models. Among which, 15,16-dihydrotanshinone I (DHT) has received much attention in recent years. In this systematical review, we carefully selected, analyzed, and summarized high-quality publications related to pharmacological effects and the underlying mechanisms of DHT. DHT has anti-cancer, cardiovascular protective, anti-inflammation, anti-Alzheimer's disease, and other effects. Furthermore, several molecules such as hypoxia-inducible factor (HIF-1α), human antigen R (HuR), acetylcholinesterase (AchE), etc. have been identified as the potential targets for DHT. The diverse pharmacological activities of DHT provide scientific evidence for the local and traditional uses of Salvia miltiorrhiza Bunge. We concluded that DHT might serve as a lead compound for drug discovery in related diseases while further in-depth investigations are still needed.

    Topics: Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Biological Products; Cardiovascular Diseases; Furans; Humans; Neuroprotective Agents; Phenanthrenes; Quinones; Salvia miltiorrhiza

2019